Ivana Galetić

Carboxyl-Terminal Modulator Protein (CTMP), a Negative Regulator of PKB/Akt and v-Akt at the Plasma Membrane

Sauveur-Michel Maira, Ivana Galetić, Derek P. Brazil et al. · Science · 2001 · 262 citations

Life Sciences, Biochemistry, Molecular Biology +15

Phase III study of nilotinib versus best supportive care with or without a TKI in patients with gastrointestinal stromal tumors resistant to or intolerant of imatinib and sunitinib

Peter Reichardt, Jean‐Yves Blay, Hans Gelderblom et al. · Annals of Oncology · 2012 · 140 citations · Full text

Medicine, Oncology, Pharmacotherapy +10

First-in-Human Safety, Imaging, and Dosimetry of a Carbonic Anhydrase IX–Targeting Peptide, [⁶⁸Ga]Ga-DPI-4452, in Patients with Clear Cell Renal Cell Carcinoma

Michael S. Hofman, Ben Tran, Darren R. Feldman et al. · Journal of Nuclear Medicine · 2024 · 62 citations · Full text

Medicine, Nuclear Medicine, Oncology +15

Negative Regulation of ERK and Elk by Protein Kinase B Modulates c-fos Transcription

Ivana Galetić, Sauveur-Michel Maira, Mirjana Andjelković et al. · Journal of Biological Chemistry · 2003 · 46 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +17

Effects of Yogurt and Applesauce on the Oral Bioavailability of Nilotinib in Healthy Volunteers

Ophelia Yin, Marc S. Rudoltz, Ivana Galetić et al. · The Journal of Clinical Pharmacology · 2011 · 15 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17